Item 7.01. Regulation FD Disclosure
On
Item 9.01. Financial Statements and Exhibits.
(d)
Exhibits Item
99.1 Press release dated
© Edgar Online, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.155 USD | -1.41% | +0.96% | +11.27% |
15/05 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
15/05 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M | MT |
Item 7.01. Regulation FD Disclosure
On
Item 9.01. Financial Statements and Exhibits.
(d)
Exhibits Item
99.1 Press release dated
© Edgar Online, source
1st Jan change | Capi. | |
---|---|---|
+11.27% | 1.78Cr | |
+37.62% | 73TCr | |
-7.96% | 35TCr | |
+15.66% | 33TCr | |
-0.35% | 28TCr | |
+13.47% | 24TCr | |
+7.35% | 21TCr | |
-6.42% | 20TCr | |
+3.92% | 16TCr | |
-2.14% | 16TCr |